Ebola treatment trial: two drugs identified as more effective
Two out of the four drugs tested in a multi-drug randomised control trial have been found more effective in treating Ebola, the World Health Organization announced on Monday. The Data and Safety Monitoring Board, an independent body that has been reviewing interim safety and efficacy data, has therefore recommended that the study be stopped and that all future patients be randomized to receive either REGN-EB3 or mAb114, in what is being considered an extension phase of the study.
Challenges and opportunities in disease forecasting in outbreak settings: A case study of measles in Lola Prefecture, Guinea
Graham, M., Suk, J.E., Takahashi, S., Jessica Metcalf, C., Paez Jimenez, A., Prikazsky, V., Ferrari, M.J., Lessler, J.
Epidemiological update: increase in reporting of human cases of A(H5N1) influenza, Egypt, 9 April 2015
Epidemiological update: increase in reporting of human cases of A(H5N1) influenza, Egypt
ECDC in the field (Ebola missions to West Africa)
As reinforcement to help fight Ebola in the affected West African countries, during the 2013-2016 outbreak, the ECDC deployed epidemiologists to support surveillance and response in Guinea.